ArticleNature communications2020

SGLT2 inhibition modulates NLRP3 inflammasome activity via ketones and insulin in diabetes with cardiovascular disease.

So Ra Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.